UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Impact of FcγRIIa-FcγRIIIa Polymorphisms and KRAS Mutations on the Clinical Outcome of Patients With Metastatic Colorectal Cancer Treated With Cetuximab Plus Irinotecan

Journal of clinical oncology, 2009-03, Vol.27 (7), p.1122-1129

2009

Volltextzugriff (PDF)

TERT Promoter Alterations in Glioblastoma: A Systematic Review

Cancers, 2021-03, Vol.13 (5), p.1147

2021

Volltextzugriff (PDF)

Circulating PIK3CA mutation detection at diagnosis in non-metastatic inflammatory breast cancer patients

Scientific reports, 2021-12, Vol.11 (1), p.24041-24041, Article 24041

2021

Volltextzugriff (PDF)

Circulating ESR1 mutations at the end of aromatase inhibitor adjuvant treatment and after relapse in breast cancer patients

Breast cancer research : BCR, 2018-05, Vol.20 (1), p.40-5, Article 40

2018

Volltextzugriff (PDF)

Circulating DNA changes are predictive of disease progression after transarterial chemoembolization

International journal of cancer, 2022-02, Vol.150 (3), p.532-541

2022

Volltextzugriff (PDF)

Clinical relevance of circulating ESR1 mutations during endocrine therapy for advanced hormone-dependent endometrial carcinoma

BMC cancer, 2023-11, Vol.23 (1), p.1-1061, Article 1061

2023

Volltextzugriff (PDF)

Short report: Monitoring ESR1 mutations by circulating tumor DNA in aromatase inhibitor resistant metastatic breast cancer

International journal of cancer, 2015-11, Vol.137 (10), p.2513-2519

2015

Volltextzugriff (PDF)

Risk of early progression according to circulating ESR1 mutation, CA-15.3 and cfDNA increases under first-line anti-aromatase treatment in metastatic breast cancer

Breast cancer research : BCR, 2020-05, Vol.22 (1), p.56-56, Article 56

2020

Volltextzugriff (PDF)

Impact of Taxanes, Endocrine Therapy, and Deleterious Germline BRCA Mutations on Anti-müllerian Hormone Levels in Early Breast Cancer Patients Treated With Anthracycline- and Cyclophosphamide-Based Chemotherapy

Frontiers in oncology, 2019-07, Vol.9, p.575-575

2019

Volltextzugriff (PDF)

ESR1 mutations in breast cancer

Aging (Albany, NY.), 2017-01, Vol.9 (1), p.3-4

2017

Volltextzugriff (PDF)

Prognostic value of HPV circulating tumor DNA detection and quantification in locally advanced cervical cancer

Frontiers in oncology, 2024-07, Vol.14, p.1382008

2024

Volltextzugriff (PDF)

Comparison of the quantification of KRAS mutations by digital PCR and E-ice-COLD-PCR in circulating-cell-free DNA from metastatic colorectal cancer patients

Clinica chimica acta, 2017-02, Vol.465, p.1-4

2017

Volltextzugriff (PDF)

Prognostic value of circulating short-length DNA fragments in unresected glioblastoma patients

Translational oncology, 2024-04, Vol.42, p.101897-101897, Article 101897

2024

Volltextzugriff (PDF)

Deleterious impact of a generic temozolomide formulation compared with brand‐name product on the kinetic of platelet concentration and survival in newly diagnosed glioblastoma

Fundamental & clinical pharmacology, 2020-08, Vol.34 (4), p.484-494

2020

Volltextzugriff (PDF)

Metastatic colorectal cancer KRAS genotyping in routine practice: results and pitfalls

Modern pathology, 2011-08, Vol.24 (8), p.1090-1100

2011

Volltextzugriff (PDF)

Early platelet variation during concomitant chemo-radiotherapy predicts adjuvant temozolomide-induced thrombocytopenia in newly diagnosed glioblastoma patients

Supportive care in cancer, 2019-02, Vol.27 (2), p.477-484

2019

Volltextzugriff (PDF)

FOLFIRINOX relative dose intensity and disease control in advanced pancreatic adenocarcinoma

Therapeutic advances in medical oncology, 2021, Vol.13, p.17588359211029825-17588359211029825

2021

Volltextzugriff (PDF)

Acute and long-term gastrointestinal consequences of chemotherapy

Baillière's best practice & research. Clinical gastroenterology, 2009-02, Vol.23 (1), p.113-124

2009

Volltextzugriff (PDF)

Usefulness of the Serum Carcinoembryonic Antigen Kinetic for Chemotherapy Monitoring in Patients With Unresectable Metastasis of Colorectal Cancer

Journal of clinical oncology, 2008-08, Vol.26 (22), p.3681-3686

2008

Volltextzugriff (PDF)

Impact of nutritional parameter variations during definitive chemoradiotherapy in locally advanced oesophageal cancer

Digestive and liver disease, 2014-03, Vol.46 (3), p.270-275

2014

Volltextzugriff (PDF)

Predictive factors of survival in patients treated with definitive chemoradiotherapy for squamous cell esophageal carcinoma

World journal of gastroenterology : WJG, 2006-07, Vol.12 (26), p.4185

2006

Volltextzugriff (PDF)

Early Evaluation of Circulating Tumor DNA as Marker of Therapeutic Efficacy in Metastatic Colorectal Cancer Patients (PLACOL Study)

Clinical cancer research, 2017-09, Vol.23 (18), p.5416-5425

2017

Volltextzugriff (PDF)

Simultaneous detection of EGFR amplification and EGFRvIII variant using digital PCR-based method in glioblastoma

Acta neuropathologica communications, 2020-04, Vol.8 (1), p.52-52, Article 52

2020

Volltextzugriff (PDF)

Esophageal cancer in the elderly: an analysis of the factors associated with treatment decisions and outcomes

BMC cancer, 2010-09, Vol.10 (1), p.510-510, Article 510

2010

Volltextzugriff (PDF)

1 – 25 von 179

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(163)
Mit Volltextzugriff
(155)

Publikationsform

Sprache

Englisch
(160)
Französisch
(19)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Impact of FcγRIIa-FcγRIIIa Polymorphisms and KRAS Mutations on the Clinical Outcome of Patients With Metastatic Colorectal Cancer Treated With Cetuximab Plus Irinotecan

TERT Promoter Alterations in Glioblastoma: A Systematic Review

Circulating PIK3CA mutation detection at diagnosis in non-metastatic inflammatory breast cancer patients

Circulating ESR1 mutations at the end of aromatase inhibitor adjuvant treatment and after relapse in breast cancer patients

Circulating DNA changes are predictive of disease progression after transarterial chemoembolization

Clinical relevance of circulating ESR1 mutations during endocrine therapy for advanced hormone-dependent endometrial carcinoma

Short report: Monitoring ESR1 mutations by circulating tumor DNA in aromatase inhibitor resistant metastatic breast cancer

Risk of early progression according to circulating ESR1 mutation, CA-15.3 and cfDNA increases under first-line anti-aromatase treatment in metastatic breast cancer

Impact of Taxanes, Endocrine Therapy, and Deleterious Germline BRCA Mutations on Anti-müllerian Hormone Levels in Early Breast Cancer Patients Treated With Anthracycline- and Cyclophosphamide-Based Chemotherapy

ESR1 mutations in breast cancer

Prognostic value of HPV circulating tumor DNA detection and quantification in locally advanced cervical cancer

Comparison of the quantification of KRAS mutations by digital PCR and E-ice-COLD-PCR in circulating-cell-free DNA from metastatic colorectal cancer patients

Kinetics, prognostic and predictive values of ESR1 circulating mutations in metastatic breast cancer patients progressing on aromatase inhibitor

Prognostic value of circulating short-length DNA fragments in unresected glioblastoma patients

Deleterious impact of a generic temozolomide formulation compared with brand‐name product on the kinetic of platelet concentration and survival in newly diagnosed glioblastoma

Metastatic colorectal cancer KRAS genotyping in routine practice: results and pitfalls

Early platelet variation during concomitant chemo-radiotherapy predicts adjuvant temozolomide-induced thrombocytopenia in newly diagnosed glioblastoma patients

FOLFIRINOX relative dose intensity and disease control in advanced pancreatic adenocarcinoma

Acute and long-term gastrointestinal consequences of chemotherapy

Usefulness of the Serum Carcinoembryonic Antigen Kinetic for Chemotherapy Monitoring in Patients With Unresectable Metastasis of Colorectal Cancer

Impact of nutritional parameter variations during definitive chemoradiotherapy in locally advanced oesophageal cancer

Predictive factors of survival in patients treated with definitive chemoradiotherapy for squamous cell esophageal carcinoma

Early Evaluation of Circulating Tumor DNA as Marker of Therapeutic Efficacy in Metastatic Colorectal Cancer Patients (PLACOL Study)

Simultaneous detection of EGFR amplification and EGFRvIII variant using digital PCR-based method in glioblastoma

Esophageal cancer in the elderly: an analysis of the factors associated with treatment decisions and outcomes

Suchergebnisse filtern